Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Enrique Poradosu currently holds 1,806,319 shares of Nuvectis Pharma, Inc. (NVCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Enrique Poradosu has been a net buyer of NVCT stock. They have purchased $35.0K and sold $0 worth of shares.
Enrique Poradosu's most recent insider trade was on Jan 6, 2026, when they sold 150,000 shares at $0.00 per share.
Enrique Poradosu serves as Executive at Nuvectis Pharma, Inc. (NVCT). They have executed 10 insider transactions totaling $35.0K over their tenure at the company.
Enrique Poradosu holds the position of Executive at Nuvectis Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Enrique Poradosu has shown a buying trading pattern, with $35.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Enrique Poradosu was on Feb 4, 2022, when they purchased $12.7K worth of NVCT shares. This transaction involved 3,800 shares at $3.35 per share.
Enrique Poradosu currently owns 1,806,319 shares of Nuvectis Pharma, Inc. (NVCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Enrique Poradosu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Enrique Poradosu has 10 Form 4 filings on record as an insider at Nuvectis Pharma, Inc..
Set alerts for Enrique Poradosu and 40,000+ other insiders.